FdaApplication
BLA 761411
Identifiers
- fda_app_no: BLA761411
Properties
| Property | Value |
|---|---|
| applicant_name | Incyte Corporation |
| application_type | BLA |
| approval_date | 2024-08-14 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NIKTIMVO | axatilimab-csfr | 50MG/ML | Injection |
| NIKTIMVO | — | 22MG/2.2ML (10MG/ML) | Injection |
| NIKTIMVO | — | 22MG/0.44ML (50MG/ML) | Injection |
| NIKTIMVO | — | 9MG/0.18ML (50MG/ML) | Injection |
| NIKTIMVO | — | 9MG/0.9ML (10MG/ML) | Injection |
5 products